Improving Outcomes in Pediatric Leukemia with Big Data
This event has passed and can no longer be viewed
This event was presented live or live-streamed and has not been designated for on-demand presentation.
This Pediatric Hematology-Oncology Research Seminar Series session will take place on Thursday, January 6, 2022 at 8:00 A.M. Live attendance for this session will only be available through Zoom.
Activity Information
Needs Statement
Clinical and research faculty, graduate and medical students, clinical and postdoctoral fellows, and research nurses in pediatric hematology-oncology need to be regularly updated on the latest data from clinical trials in pediatric patients with hematological-oncological disorders, on the advances in the development of targeted therapies, on the developments in ethical/legal issues related to end of life care, and on the new practice standards for follow-up care for long-term survivors. The series aims to increase knowledge and skills of the learners in these topic areas in order to enhance the quality of care, increase patient safety, and improve patient outcomes.
Educational Objectives
At the conclusion of the sessions, the participants should be able to:
- Distinguish different sources and limitations of big data in pediatric leukemia.
- Describe how big data may improve adverse event identification in pediatric leukemia.
- Discuss how big data may be combined with other data sources to answer clinical questions in pediatric leukemia.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
- Nurses
Specialties
- Nuclear Medicine
- Pathology
- Pediatrics
Interest Groups
- Hospital Medicine
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity Director
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Richard Aplenc, M.D., Ph.D.
Professor, Mai and Harry F. West Endowed Chair
Children’s Hospital of Philadelphia
Disclosure:
Nothing to disclose.
Activity Director
-
Terzah Horton, M.D., Ph.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
- Research Support: Takeda Pharmaceuticals
Planning Committee Members
-
Jonathan Flanagan, Ph.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Terzah Horton, M.D., Ph.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
- Research Support: Takeda Pharmaceuticals
-
YoungNa Lee-Kim, M.D.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Donald Williams Parsons, M.D., Ph.D.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Health Topics
Presenter: